Despite no differences in primary tumor growth kinetics (Fig. 5b), T367A-EZH2 signficantly reduced the lung metastatic burden and ability to metastasize compared to WT-EZH2 (Fig. 5c–e). This evidence concerns the gene EZH2 and neoplasm.